Thomas Geisbert, PhD, MS

Projects

Projects per year 2011 2012 2013 2014 2015 2017 2019 2021 2022 2023 2027

• 10 Active
• 72 Finished

Projects per year

Search results

• Active

  Task 1: Dose Ranging

  Geisbert, T. (PI)

  Mapp Biopharmaceutical, Inc.

  11/1/23 → 12/31/24

  Project: Research project

• HTS for small molecule drug development for henipaviruses

  Geisbert, T. (PI)

  University of Illinois at Chicago

  11/29/22 → 9/30/25

  Project: Research project

• MCDC2204-011: Development of Vaccines to Prevent Crimean Congo Hemorrhagic Fever Virus or Henipavirus Infections in Humans

  Geisbert, T. (PI)

  Advanced Technology International

  11/21/22 → 12/31/27

  Project: Research project

• Recombinant HeV-sG Vaccine Formulation and Delivery via Microneedle Patch

  Geisbert, T. (PI)

  Henry M. Jackson Foundation for the Advancement of Military Medicine

  11/30/21 → 11/29/24

  Project: Research project

• Task Order 1

  Geisbert, T. (PI)

  Arbutus Biopharma, Inc

  6/1/21 → 5/31/25

  Project: Research project

• Preclinical development of a vaccine for Nipah virus

  Geisbert, T. (PI)

  National Institute of Allergy and Infectious Diseases

  3/11/21 → 2/28/26

  Project: Research project

• Development of a rVSV-Vectored Vaccine for Lassa Virus: Nonhuman Primate Efficacy and Immunogenicity Studies

  Geisbert, T. (PI)

  Emergent Product Development Gaithersburg, Inc

  1/1/21 → 12/1/24

  Project: Research project

• Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine

  Geisbert, T. (PI)

  National Institute of Allergy and Infectious Diseases

  7/15/20 → 6/30/25

  Project: Research project

• Advancement of Vaccines and Therapies for Henipaviruses

  Geisbert, T. (PI)

  Henry M. Jackson Foundation for the Advancement of Military Medicine

  3/20/19 → 2/28/25

  Project: Research project

• Core A

  Geisbert, T. (PI)

  National Institute of Allergy and Infectious Diseases

  3/8/19 → 2/28/25

  Project: Research project

• Finished

  Assessment of Antiviral Activity of MTP Material against Ebola and Marburg in Vitro

  Geisbert, T. (PI)

  FetTech, LLC

  11/1/23 → 4/30/24

  Project: Research project

• Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease

  Geisbert, T. (PI)

  Abvacc

  8/11/23 → 1/1/24

  Project: Research project

• Broadly Protective Antibodies for the Treatment of Ebola Virus Disease

  Geisbert, T. (PI)

  Abvacc

  5/12/23 → 4/30/24

  Project: Research project

• Panacea- Relevant to Enhancing the Mission Effectiveness of Military Personnel and Supporting Platforms, Systems, Components, or Materials

  Geisbert, T. (PI)

  Access to Advanced Health Institute

  4/15/23 → 7/31/24

  Project: Research project

• Efficacy of IBT-T03-T, IBT-T03-RCB#19, and IBT-T03-RCB#3 when administered by IV infusion in NHP MARV-Angola challenge model

  Geisbert, T. (PI)

  Abvacc

  3/1/23 → 1/31/24

  Project: Research project

• MCDC2204-006: Vaccine Development for Protection from Nipah and Hendra Virus Disease

  Geisbert, T. (PI)

  Advanced Technology International

  11/21/22 → 3/17/23

  Project: Research project

• Prophylactic Evaluation of a Nipah Virus Monoclonal Antibody Medical Countermeasure

  Geisbert, T. (PI)

  Mapp Biopharmaceutical, Inc.

  9/27/22 → 2/29/24

  Project: Research project

• Development of a Sudan Ebolavirus Vaccine Utilizing a Live Vesicular Stomatitis Virus Chimera Platform

  Geisbert, T. (PI)

  International AIDS Vaccine Initiative

  9/2/22 → 12/31/23

  Project: Research project

• A Fully Integrated Point-of-Care Test for Ebola

  Geisbert, T. (PI)

  DUKE UNIVERSITY

  9/1/22 → 8/31/24

  Project: Research project

• Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD)

  Geisbert, T. (PI)

  InBios International

  7/1/22 → 2/28/24

  Project: Research project

• Marburg Virus Prophylactic Medical Countermeasure

  Geisbert, T. (PI)

  Mapp Biopharmaceutical, Inc.

  4/6/22 → 2/28/23

  Project: Research project

• Intrinsically-Enhanced Ebola Virus Like Particles for Increased Potency and Immune Memory

  Geisbert, T. (PI)

  Icahn School of Medicine at Mount Sinai

  3/24/22 → 5/31/23

  Project: Research project

• Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection

  Geisbert, T. (PI)

  Icahn School of Medicine at Mount Sinai

  3/18/22 → 6/30/24

  Project: Research project

• Efficacy of Marburg virus monoclonal antibody (IBT-T03) in guinea pig model of MARV-Angola infection

  Geisbert, T. (PI)

  Abvacc

  11/11/21 → 6/30/22

  Project: Research project

• Determination of the EC50 and EC90 of favipiravir against SARS-CoV-2

  Geisbert, T. (PI)

  FUJIFILM Pharmaceutical USA Inc

  10/1/21 → 8/31/22

  Project: Research project

• Development of an aerosol induced nonhuman primate model of Lassa fever

  Geisbert, T. (PI)

  Advanced Technology International

  7/30/21 → 8/31/24

  Project: Research project

• In Vitro Lassa Virus Resistance Studies with ARN-75039

  Geisbert, T. (PI)

  Arisan Therapeutics Corporation

  6/1/21 → 6/30/22

  Project: Research project

• Evolution of Anti-Filovirus B Cell Responses and Mechanisms of Protection

  Geisbert, T. (PI)

  Abvacc

  5/18/21 → 5/17/22

  Project: Research project

• Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection

  Geisbert, T. (PI)

  Georgia State University

  7/13/20 → 11/15/21

  Project: Research project

• Study 3, AGM vaccine dose-down study (research grade) for A Subunit Vaccine (HeV-sG) to Protect Against Nipah and Hendra Disease

  Geisbert, T. (PI)

  Auro Vaccines, LLC

  7/6/20 → 2/28/21

  Project: Research project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T. (PI)

  Eli Lilly and Company

  4/16/20 → 4/1/23

  Project: Research project

• Development of a Recombinant VSV-Based Vaccine for Lassa Fever

  Geisbert, T. (PI)

  Department of Defense

  9/1/19 → 8/31/23

  Project: Research project

• Development of a Recombinant VSV-Based Vaccine for Nipah Virus

  Geisbert, T. (PI)

  Department of Defense

  9/1/19 → 8/31/23

  Project: Research project

• MR191_An Immunoprotectant for Marburg Virus

  Geisbert, T. (PI)

  Mapp Biopharmaceutical, Inc.

  7/1/19 → 6/30/21

  Project: Research project

• Consortium for Immunotherapeutics against Emerging Viral Threats

  Geisbert, T. (PI)

  La Jolla Institute for Immunology

  5/1/19 → 4/30/24

  Project: Research project

• A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera

  Geisbert, T. (PI)

  International AIDS Vaccine Initiative

  3/27/19 → 6/30/20

  Project: Research project

• Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies

  Geisbert, T. (PI)

  Zalgen Labs, LLC

  12/24/18 → 11/30/23

  Project: Research project

• Advanced Development of Multivalent Vaccine Candidates for Filovirus and Lassa Fever

  Geisbert, T. (PI)

  Profectus BioSciences, Inc.

  4/1/18 → 6/30/19

  Project: Research project

• Development of sG as a human vaccine against Nipah/Hendra

  Geisbert, T. (PI)

  Profectus BioSciences, Inc.

  3/1/18 → 12/31/18

  Project: Research project

• Therapeutics to Treat Viral Hemorrhagic Fevers

  Geisbert, T. (PI)

  SNKT, LLC

  2/1/18 → 2/14/19

  Project: Research project

• Nonhuman Primate Hemorrhagic Fever Virus Challenge Studies

  Geisbert, T. (PI)

  Leidos Biomedical Research, Inc.

  12/11/17 → 12/1/18

  Project: Research project

• Structure-based Design of Novel Lassa Virus Glycoproteins for Vaccine Development

  Geisbert, T. (PI)

  Tulane University Medical Center

  7/14/17 → 6/30/24

  Project: Research project

• Preclinical Evaluation of a Potent Lassa Fever Immunotherapeutic Antibody Cocktail

  Geisbert, T. (PI)

  Tulane University Medical Center

  6/26/17 → 5/31/24

  Project: Research project

• Preclinical Development of a Thermostable Trivalent Filovirus Vaccine

  Geisbert, T. (PI)

  UNIVERSITY OF HAWAII AT MANOA

  6/20/17 → 5/31/23

  Project: Research project

• Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever

  Geisbert, T. (PI)

  National Institute of Allergy and Infectious Diseases

  6/1/17 → 5/31/23

  Project: Research project

• Consortium for Immunotherapeutics against Viral Hemorrhagic Fever

  Geisbert, T. (PI)

  Scripps Research Institute

  3/1/17 → 5/31/19

  Project: Research project

• Mechanisms of Evasion of the Innate and Adaptive Immune Responses to Filoviruses

  Geisbert, T. (PI)

  Georgia State University

  3/1/17 → 2/28/18

  Project: Research project

• Determination and Understanding of Quantitative Infectious Dose for Ebola Virus

  Geisbert, T. (PI)

  Defense Threat Reduction Agency

  2/1/17 → 7/31/20

  Project: Research project

• Filovirus Genes Preserved in Mammalian Genomes: Impact on Viral Replication

  Geisbert, T. (PI)

  Georgia State University

  11/1/16 → 10/31/17

  Project: Research project

• Development ofMB-2003, a novel monoclonal antibody (mAB) based countermeasure with antiviral activity against Ebola virus

  Geisbert, T. (PI)

  Mapp Biopharmaceutical, Inc.

  4/19/16 → 5/31/17

  Project: Research project